{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:27:13Z","timestamp":1779290833720,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T00:00:00Z","timestamp":1372982400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Post-surgery therapies are given to early-stage breast cancer patients due to the possibility of residual micrometastasis, and optimized by clincopathological parameters such as tumor stage, and hormone receptor\/lymph node status. However, current efficacy of post-surgery therapies is unsatisfactory, and may be varied according to unidentified patient genetic factors. Increases of breast cancer occurrence and recurrence have been associated with dyslipidemia, which can attribute to other known risk factors of breast cancer including obesity, diabetes and metabolic syndrome. Thus we reasoned that dyslipidemia-associated nucleotide polymorphisms (SNPs) on the <jats:italic>APOA1<\/jats:italic>\/<jats:italic>C3<\/jats:italic>\/<jats:italic>A5<\/jats:italic> gene cluster may predict breast cancer risk and tumor progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed the distribution of 5 selected <jats:italic>APOA1<\/jats:italic>\/<jats:italic>C3<\/jats:italic>\/<jats:italic>A5<\/jats:italic> SNPs in recruited Taiwanese breast cancer patients (n=223) and healthy controls (n=162). The association of SNP (<jats:italic>APOA1<\/jats:italic> rs670) showing correlation with breast cancer with baseline and follow-up parameters was further examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>\n              <jats:italic>APOA1<\/jats:italic> rs670 A allele carriage was higher in breast cancer patients than controls (59.64% <jats:italic>vs<\/jats:italic>. 48.77%, p=0.038). The rs670 A allele carrying patients showed less favorable baseline phenotype with positive lymph nodes (G\/A: OR=3.32, 95%\u2009CI=1.77-6.20, p&lt;0.001; A\/A: OR=2.58, 95%\u2009CI=1.05-6.32, p=0.039) and negative hormone receptor expression (A\/A: OR=4.85, 95%CI=1.83-12.83, p=0.001) in comparison to G\/G carriers. Moreover, rs670 A\/A carrying patients had higher risks in both tumor recurrence (HR=3.12, 95%\u2009CI=1.29-7.56, p=0.012) and mortality (HR=4.36, 95%\u2009CI=1.52-12.47, p=0.006) than patients with no A alleles after adjustments for associated baseline parameters. Furthermore, the prognostic effect of rs670 A\/A carriage was most evident in lymph node-negative patients, conferring to the highest risks of recurrence (HR=4.98, 95%\u2009CI=1.40-17.70, p=0.013) and mortality (HR=9.87, 95%CI=1.60-60.81, p=0.014) than patients with no A alleles.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>\n              <jats:italic>APOA1<\/jats:italic> rs670 A\/A carriage showed poor post-surgery prognosis in Taiwanese lymph node-negative breast cancer patients, whose prognosis were considered better and adjuvant treatment might be less stringent according to currently available assessment protocols. Our findings suggest that <jats:italic>APOA1<\/jats:italic> rs670 indicate a post-surgery risk of breast cancer disease progression, and that carriers of this SNP may benefit from more advanced disease monitoring and therapy regimens than the current regular standards. Furthermore, control of lipid homeostasis might protect <jats:italic>APOA1<\/jats:italic> rs670 minor allele carriers from breast cancer occurrence and progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-13-330","type":"journal-article","created":{"date-parts":[[2013,7,5]],"date-time":"2013-07-05T10:14:51Z","timestamp":1373019291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The dyslipidemia-associated SNP on the APOA1\/C3\/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study"],"prefix":"10.1186","volume":"13","author":[{"given":"Mei-Chi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chiang","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Ling","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kung-Chia","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,5]]},"reference":[{"issue":"12","key":"3963_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrclinonc.2010.192","volume":"7","author":"L Hutchinson","year":"2010","unstructured":"Hutchinson L: Breast cancer: challenges, controversies, breakthroughs. Nat Rev Clin Oncol. 2010, 7 (12): 669-670. 10.1038\/nrclinonc.2010.192.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"3963_CR2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrclinonc.2010.170","volume":"7","author":"C Oakman","year":"2010","unstructured":"Oakman C, Santarpia L, Di Leo A: Breast cancer assessment tools and optimizing adjuvant therapy. Nat Rev Clin Oncol. 2010, 7 (12): 725-732. 10.1038\/nrclinonc.2010.170.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"3963_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1023\/A:1006468514396","volume":"63","author":"SH Cheng","year":"2000","unstructured":"Cheng SH, Tsou MH, Liu MC, Jian JJ, Cheng JC, Leu SY, Hsieh CY, Huang AT: Unique features of breast cancer in Taiwan. Breast Cancer Res Treat. 2000, 63 (3): 213-223. 10.1023\/A:1006468514396.","journal-title":"Breast Cancer Res Treat"},{"issue":"4\u20135","key":"3963_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jsbmb.2009.12.017","volume":"118","author":"CS Huang","year":"2010","unstructured":"Huang CS, Lin CH, Lu YS, Shen CY: Unique features of breast cancer in Asian women\u2013breast cancer in Taiwan as an example. J Steroid Biochem Mol Biol. 2010, 118 (4\u20135): 300-303.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3963_CR5","doi-asserted-by":"publisher","first-page":"506868","DOI":"10.1155\/2012\/506868","volume":"2012","author":"CE Champ","year":"2012","unstructured":"Champ CE, Volek JS, Siglin J, Jin L, Simone NL: Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data?. Int J Breast Cancer. 2012, 2012: 506868-","journal-title":"Int J Breast Cancer"},{"issue":"6","key":"3963_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1634\/theoncologist.2011-0050","volume":"16","author":"C La Vecchia","year":"2011","unstructured":"La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B: Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist. 2011, 16 (6): 726-729. 10.1634\/theoncologist.2011-0050.","journal-title":"Oncologist"},{"issue":"9710","key":"3963_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","volume":"375","author":"RH Eckel","year":"2010","unstructured":"Eckel RH, Alberti KG, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet. 2010, 375 (9710): 181-183. 10.1016\/S0140-6736(09)61794-3.","journal-title":"Lancet"},{"issue":"9","key":"3963_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1515\/CCLM.2007.263","volume":"45","author":"SJ Chang","year":"2007","unstructured":"Chang SJ, Hou MF, Tsai SM, Wu SH, Hou LA, Ma H, Shann TY, Tsai LY: The association between lipid profiles and breast cancer among Taiwanese women. Clin Chem Lab Med. 2007, 45 (9): 1219-1223.","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"3963_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/01635589709514539","volume":"27","author":"PJ Goodwin","year":"1997","unstructured":"Goodwin PJ, Boyd NF, Hanna W, Hartwick W, Murray D, Qizilbash A, Redwood S, Hood N, DelGiudice ME, Sidlofsky S, et al: Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer. 1997, 27 (3): 284-292. 10.1080\/01635589709514539.","journal-title":"Nutr Cancer"},{"issue":"2","key":"3963_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1158\/1055-9965.EPI-08-0133","volume":"18","author":"Y Kim","year":"2009","unstructured":"Kim Y, Park SK, Han W, Kim DH, Hong YC, Ha EH, Ahn SH, Noh DY, Kang D, Yoo KY: Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea. Cancer Epidemiol Biomarkers Prev. 2009, 18 (2): 508-515. 10.1158\/1055-9965.EPI-08-0133.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1\u20132","key":"3963_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11010-005-2993-4","volume":"268","author":"V Michalaki","year":"2005","unstructured":"Michalaki V, Koutroulis G, Syrigos K, Piperi C, Kalofoutis A: Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer. Mol Cell Biochem. 2005, 268 (1\u20132): 19-24.","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"3963_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10549-005-6654-9","volume":"94","author":"M Bahl","year":"2005","unstructured":"Bahl M, Ennis M, Tannock IF, Hux JE, Pritchard KI, Koo J, Goodwin PJ: Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res Treat. 2005, 94 (2): 135-144. 10.1007\/s10549-005-6654-9.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"3963_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10549-009-0603-y","volume":"121","author":"A Emaus","year":"2010","unstructured":"Emaus A, Veierod MB, Tretli S, Finstad SE, Selmer R, Furberg AS, Bernstein L, Schlichting E, Thune I: Metabolic profile, physical activity, and mortality in breast cancer patients. Breast Cancer Res Treat. 2010, 121 (3): 651-660. 10.1007\/s10549-009-0603-y.","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"3963_CR14","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/jnci\/djh216","volume":"96","author":"AS Furberg","year":"2004","unstructured":"Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I: Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst. 2004, 96 (15): 1152-1160. 10.1093\/jnci\/djh216.","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"3963_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/aje\/kwq491","volume":"173","author":"MJ Shrubsole","year":"2011","unstructured":"Shrubsole MJ, Shu XO, Li HL, Cai H, Yang G, Gao YT, Gao J, Zheng W: Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol. 2011, 173 (10): 1171-1182. 10.1093\/aje\/kwq491.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"3963_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/CEJ.0b013e3283354918","volume":"19","author":"G Fagherazzi","year":"2010","unstructured":"Fagherazzi G, Fabre A, Boutron-Ruault MC, Clavel-Chapelon F: Serum cholesterol level, use of a cholesterol-lowering drug, and breast cancer: results from the prospective E3N cohort. Eur J Cancer Prev. 2010, 19 (2): 120-125. 10.1097\/CEJ.0b013e3283354918.","journal-title":"Eur J Cancer Prev"},{"issue":"19","key":"3963_CR17","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1093\/jnci\/djr291","volume":"103","author":"TP Ahern","year":"2011","unstructured":"Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sorensen HT, Lash TL: Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst. 2011, 103 (19): 1461-1468. 10.1093\/jnci\/djr291.","journal-title":"J Natl Cancer Inst"},{"key":"3963_CR18","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1038\/onc.2012.113","volume":"32","author":"N Alikhani","year":"2013","unstructured":"Alikhani N, Ferguson RD, Novosyadlyy R, Gallagher EJ, Scheinman EJ, Yakar S, Leroith D: Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model. Oncogene. 2013, 32: 961-967. 10.1038\/onc.2012.113.","journal-title":"Oncogene"},{"issue":"2","key":"3963_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/01.mol.0000162320.54795.68","volume":"16","author":"CQ Lai","year":"2005","unstructured":"Lai CQ, Parnell LD, Ordovas JM: The APOA1\/C3\/A4\/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol. 2005, 16 (2): 153-166. 10.1097\/01.mol.0000162320.54795.68.","journal-title":"Curr Opin Lipidol"},{"issue":"4","key":"3963_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1155\/2005\/195078","volume":"21","author":"S Chhabra","year":"2005","unstructured":"Chhabra S, Narang R, Lakshmy R, Das N: APOA1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among northern Indians. Dis Markers. 2005, 21 (4): 169-174. 10.1155\/2005\/195078.","journal-title":"Dis Markers"},{"issue":"4","key":"3963_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1046\/j.1365-2265.2003.01865.x","volume":"59","author":"YQ Ma","year":"2003","unstructured":"Ma YQ, Thomas GN, Ng MC, Critchley JA, Cockram CS, Chan JC, Tomlinson B: Association of two apolipoprotein A-I gene MspI polymorphisms with high density lipoprotein (HDL)-cholesterol levels and indices of obesity in selected healthy Chinese subjects and in patients with early-onset type 2 diabetes. Clin Endocrinol (Oxf). 2003, 59 (4): 442-449. 10.1046\/j.1365-2265.2003.01865.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"3963_CR22","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/j.1464-5491.2005.01514.x","volume":"22","author":"S Morcillo","year":"2005","unstructured":"Morcillo S, Cardona F, Rojo-Martinez G, Esteva I, Ruiz-de-Adana MS, Tinahones F, Gomez-Zumaquero JM, Soriguer F: Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus. Diabet Med. 2005, 22 (6): 782-788. 10.1111\/j.1464-5491.2005.01514.x.","journal-title":"Diabet Med"},{"issue":"2","key":"3963_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.atherosclerosis.2010.10.029","volume":"214","author":"CM Phillips","year":"2011","unstructured":"Phillips CM, Goumidi L, Bertrais S, Field MR, McManus R, Hercberg S, Lairon D, Planells R, Roche HM: Gene-nutrient interactions and gender may modulate the association between ApoA1 and ApoB gene polymorphisms and metabolic syndrome risk. Atherosclerosis. 2011, 214 (2): 408-414. 10.1016\/j.atherosclerosis.2010.10.029.","journal-title":"Atherosclerosis"},{"issue":"3","key":"3963_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000006849","volume":"90","author":"JR Reguero","year":"1998","unstructured":"Reguero JR, Cubero GI, Batalla A, Alvarez V, Hevia S, Cortina A, Coto E: Apolipoprotein A1 gene polymorphisms and risk of early coronary disease. Cardiology. 1998, 90 (3): 231-235. 10.1159\/000006849.","journal-title":"Cardiology"},{"issue":"2","key":"3963_CR25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1172\/JCI118802","volume":"98","author":"XL Wang","year":"1996","unstructured":"Wang XL, Liu SX, McCredie RM, Wilcken DE: Polymorphisms at the 5\u2032-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest. 1996, 98 (2): 372-377. 10.1172\/JCI118802.","journal-title":"J Clin Invest"},{"issue":"12","key":"3963_CR26","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","volume":"362","author":"KF Petersen","year":"2010","unstructured":"Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM, Dziura J, Lifton RP, Shulman GI: Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N Engl J Med. 2010, 362 (12): 1082-1089. 10.1056\/NEJMoa0907295.","journal-title":"N Engl J Med"},{"issue":"19","key":"3963_CR27","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/hmg\/ddg255","volume":"12","author":"JT Kao","year":"2003","unstructured":"Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW: A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet. 2003, 12 (19): 2533-2539. 10.1093\/hmg\/ddg255.","journal-title":"Hum Mol Genet"},{"issue":"5540","key":"3963_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.1064852","volume":"294","author":"LA Pennacchio","year":"2001","unstructured":"Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001, 294 (5540): 169-173. 10.1126\/science.1064852.","journal-title":"Science"},{"key":"3963_CR29","volume-title":"Nutrition and Diabetes","author":"M Hsu","year":"2013","unstructured":"Hsu M, Chang C, Lee K, Sun H, Tsai Y, Kuo P, Young K, Wu C: Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1\/C3\/A4\/A5 gene cluster. Nutrition and Diabetes. 2013, In press,"},{"issue":"3","key":"3963_CR30","doi-asserted-by":"publisher","first-page":"R180","DOI":"10.1186\/bcr770","volume":"6","author":"WC Hsiao","year":"2004","unstructured":"Hsiao WC, Young KC, Lin SL, Lin PW: Estrogen receptor-alpha polymorphism in a Taiwanese clinical breast cancer population: a case\u2013control study. Breast Cancer Res. 2004, 6 (3): R180-R186. 10.1186\/bcr770.","journal-title":"Breast Cancer Res"},{"issue":"5","key":"3963_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ejso.2006.02.010","volume":"32","author":"WC Hsiao","year":"2006","unstructured":"Hsiao WC, Cho WC, Lin PW, Lin SL, Lee WY, Young KC: Quantitative profile of estrogen receptor variants\/isoforms in Taiwanese women with breast cancer. Eur J Surg Oncol. 2006, 32 (5): 492-497. 10.1016\/j.ejso.2006.02.010.","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"3963_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005, 21 (2): 263-265. 10.1093\/bioinformatics\/bth457.","journal-title":"Bioinformatics"},{"issue":"Suppl 2","key":"3963_CR33","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.3816\/CBC.2006.s.005","volume":"6","author":"RT Chlebowski","year":"2006","unstructured":"Chlebowski RT, Anderson GL, Geller M, Col N: Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use. Clin Breast Cancer. 2006, 6 (Suppl 2): S58-S64.","journal-title":"Clin Breast Cancer"},{"issue":"3","key":"3963_CR34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s11033-010-0274-0","volume":"38","author":"B Hamrita","year":"2011","unstructured":"Hamrita B, Ben Nasr H, Gabbouj S, Bouaouina N, Chouchane L, Chahed K: Apolipoprotein A1\u201375 G\/A and +83 C\/T polymorphisms: susceptibility and prognostic implications in breast cancer. Mol Biol Rep. 2011, 38 (3): 1637-1643. 10.1007\/s11033-010-0274-0.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"3963_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1093\/jnci\/82.6.460","volume":"82","author":"NF Boyd","year":"1990","unstructured":"Boyd NF, McGuire V: Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer. J Natl Cancer Inst. 1990, 82 (6): 460-468. 10.1093\/jnci\/82.6.460.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"3963_CR36","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1021\/pr100123f","volume":"9","author":"A D\u2019Alessandro","year":"2010","unstructured":"D\u2019Alessandro A, Scaloni A, Zolla L: Human milk proteins: an interactomics and updated functional overview. J Proteome Res. 2010, 9 (7): 3339-3373. 10.1021\/pr100123f.","journal-title":"J Proteome Res"},{"issue":"9","key":"3963_CR37","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.jprot.2012.03.049","volume":"75","author":"VC Hodgkinson","year":"2012","unstructured":"Hodgkinson VC, Agarwal V, EL D, Fox JN, McManus PL, Mahapatra TK, Kneeshaw PJ, Drew PJ, Lind MJ, Cawkwell L: Pilot and feasibility study: comparative proteomic analysis by 2-DE MALDI TOF\/TOF MS reveals 14-3-3 proteins as putative biomarkers of response to neoadjuvant chemotherapy in ER-positive breast cancer. J Proteomics. 2012, 75 (9): 2745-2752. 10.1016\/j.jprot.2012.03.049.","journal-title":"J Proteomics"},{"issue":"11","key":"3963_CR38","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1021\/pr900239h","volume":"8","author":"L Cortesi","year":"2009","unstructured":"Cortesi L, Barchetti A, De Matteis E, Rossi E, Della Casa L, Marcheselli L, Tazzioli G, Lazzaretti MG, Ficarra G, Federico M, et al: Identification of protein clusters predictive of response to chemotherapy in breast cancer patients. J Proteome Res. 2009, 8 (11): 4916-4933. 10.1021\/pr900239h.","journal-title":"J Proteome Res"},{"issue":"6","key":"3963_CR39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1158\/1940-6207.CAPR-08-0084","volume":"1","author":"HJ Lee","year":"2008","unstructured":"Lee HJ, Paul S, Atalla N, Thomas PE, Lin X, Yang I, Buckley B, Lu G, Zheng X, Lou YR, et al: Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity. Cancer Prev Res (Phila). 2008, 1 (6): 476-484. 10.1158\/1940-6207.CAPR-08-0084.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"3963_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.atherosclerosis.2010.01.011","volume":"211","author":"ML Fitzgerald","year":"2010","unstructured":"Fitzgerald ML, Mujawar Z, Tamehiro N: ABC transporters, atherosclerosis and inflammation. Atherosclerosis. 2010, 211 (2): 361-370. 10.1016\/j.atherosclerosis.2010.01.011.","journal-title":"Atherosclerosis"},{"issue":"1","key":"3963_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10911-009-9109-9","volume":"14","author":"M Dean","year":"2009","unstructured":"Dean M: ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia. 2009, 14 (1): 3-9. 10.1007\/s10911-009-9109-9.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"2","key":"3963_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1055\/s-0029-1241859","volume":"42","author":"S Schimanski","year":"2010","unstructured":"Schimanski S, Wild PJ, Treeck O, Horn F, Sigruener A, Rudolph C, Blaszyk H, Klinkhammer-Schalke M, Ortmann O, Hartmann A, et al: Expression of the lipid transporters ABCA3 and ABCA1 is diminished in human breast cancer tissue. Horm Metab Res. 2010, 42 (2): 102-109. 10.1055\/s-0029-1241859.","journal-title":"Horm Metab Res"},{"issue":"7","key":"3963_CR43","first-page":"3007","volume":"32","author":"A El Roz","year":"2012","unstructured":"El Roz A, Bard JM, Huvelin JM, Nazih H: LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. Anticancer Res. 2012, 32 (7): 3007-3013.","journal-title":"Anticancer Res"},{"issue":"12","key":"3963_CR44","doi-asserted-by":"publisher","first-page":"11961","DOI":"10.1074\/jbc.M411985200","volume":"280","author":"LY Bourguignon","year":"2005","unstructured":"Bourguignon LY, Gilad E, Rothman K, Peyrollier K: Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1\/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem. 2005, 280 (12): 11961-11972. 10.1074\/jbc.M411985200.","journal-title":"J Biol Chem"},{"issue":"10","key":"3963_CR45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/jnci\/djj185","volume":"98","author":"C Holm","year":"2006","unstructured":"Holm C, Rayala S, Jirstrom K, Stal O, Kumar R, Landberg G: Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J Natl Cancer Inst. 2006, 98 (10): 671-680. 10.1093\/jnci\/djj185.","journal-title":"J Natl Cancer Inst"},{"issue":"46","key":"3963_CR46","doi-asserted-by":"publisher","first-page":"19997","DOI":"10.1073\/pnas.1009010107","volume":"107","author":"F Su","year":"2010","unstructured":"Su F, Kozak KR, Imaizumi S, Gao F, Amneus MW, Grijalva V, Ng C, Wagner A, Hough G, Farias-Eisner G, et al: Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A. 2010, 107 (46): 19997-20002. 10.1073\/pnas.1009010107.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3963_CR47","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1158\/1535-7163.MCT-11-0905","volume":"11","author":"F Su","year":"2012","unstructured":"Su F, Grijalva V, Navab K, Ganapathy E, Meriwether D, Imaizumi S, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R: HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer. Mol Cancer Ther. 2012, 11 (6): 1311-1319. 10.1158\/1535-7163.MCT-11-0905.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"3963_CR48","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10549-007-9683-8","volume":"109","author":"ML Kwan","year":"2008","unstructured":"Kwan ML, Habel LA, Flick ED, Quesenberry CP, Caan B: Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008, 109 (3): 573-579. 10.1007\/s10549-007-9683-8.","journal-title":"Breast Cancer Res Treat"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-330\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-330.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:37:51Z","timestamp":1630543071000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,5]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3963"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-330","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,5]]},"assertion":[{"value":"22 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"330"}}